IHS FormWeb
Approved Formulary
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
IHS FormWeb
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Search results for:
carbidopa-levodopa
carbidopa-levodopa
Brand names:
Sinemet, Sinemet CR
Form
Strength
TABLET, EXTENDED RELEASE, ORAL
25 mg-100 mg; 50 mg-200 mg
TABLET, ORAL
10 mg-100 mg; 25 mg-100 mg; 25 mg-250 mg
Display
Dopamine Precursors
Class:
283616
Medication comments:
Enteral Drug Administration notes.
View all
Generic
(Brand)
Comments and Considerations
Recommendations for Administration with Enteral Nutrition
carbidopa-levodopa
(
Sinemet
)
Do not need to hold tube feeds. May increase dose for desired effect
Last updated:
Oct. 11, 2020
Black Box Warnings
Bolded (not boxed): Carbidopa dosing
UpToDate
FDA DailyMed Package Insert
MedLinePlus (Patient Information)
MSDS Online
(Brand)
(Sinemet)